학술논문
Efficacy and safety of rezivertinib (BPI-7711) in patients with locally advanced or metastatic/recurrent EGFR T790M-mutated NSCLC: A phase IIb, multicenter, singlearm, open-label study.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755